Genetic or epigenetic changes in TNBC may lead to the upregulation of tumor-associated antigens, causing dysregulation of immune checkpoint proteins and inhibiting T cell activity via the PD-1/PD-L1 pathway, resulting in immune escape [19]. This evidence concerns the gene CD274 and neoplasm.